Allergic bronchopulmonary mycosis (ABPM) is a known complication of asthma and can result in progressive lung damage, respiratory failure and death. Asthma is a common disease in Saudi Arabia and until now the prevalence of ABPM has not been investigated. The aim of this study was to estimate the period prevalence of ABPM due to Aspergillus and Candida in patients with asthma. The setting was an outpatient pulmonary clinic at a university hospital in the central region of Saudi Arabia. Two hundred and sixty-four consecutive patients with asthma (150 or 57% females) were evaluated. All patients were screened for ABPM with skin prick test (SPT) using a panel of fungal antigens. Those with positive skin reactions had further clinical, immunological, respiratory and radiological assessment. ABPM was diagnosed by the presence of a minimum of five of the major criteria suggested by Rosenberg in 1977. Of the 264 patients, 62 (23%) had a positive SPT for at least one fungal allergen, of whom 44 (71%) were females (P=0?01). Seven patients (six females) were diagnosed with ABPM due to Aspergillus and (or) Candida species. Therefore, we estimate the period prevalence of ABPM to be 2?7% (95% confidence interval 1?3-5?4%). A. niger was the commonest fungal species isolated in our group. In conclusion, ABPM is not uncommon in Saudi Arabia and females seem to be more at risk. Because asthma is common, physicians need to have high index of suspicion for this disease and pursue the diagnosis with the appropriate tests.
Introduction
Fungi are common allergens in asthma and are widely prevalent both indoors and outdoors (1) (2) (3) . One consequence of exposure to these allergens is the well-recognized syndrome allergic bronchopulmonary mycosis (ABPM). ABPM is thought to result from a hypersensitivity reaction and is characterized by a number of clinical, immunological and radiological features, which were described by Rosenberg (4). If not recognized, it can progress to lung destruction, respiratory failure and death, therefore it is prudent to exclude ABPM in patients with asthma (5, 6) .
ABPM was first described in the U.K. in 1952 (7) and was related to Aspergillus (ABPA). Subsequently, this syndrome was reported in many countries and related to a wide range of fungi (8) . In Europe and U.S.A. the prevalence of ABPA was estimated to range between 1 and 28%, depending on the methods and the patient population studied (9) (10) (11) (12) . To our knowledge, no surveys of ABPM were done in the Middle East, including countries where asthma is common, such as Saudi Arabia. Therefore, this study was carried out to ascertain the period prevalence of ABPM secondary to Aspergillus and Candida in patients with asthma attending chest clinics at our hospital.
Materials and methods
The study was conducted in King Khalid University Hospital, Riyadh, which is located in the central province (Najd), Saudi Arabia. This region is mainly a desert about 400 km inland. The hospital serves both as a general hospital and a tertiary referral centre.
CLINICAL CHARACTERSTICS
Patients with asthma attending the outpatient pulmonary clinic from 15 February 1997 to 28 July 1998 were evaluated after consenting to the study. The study was approved by the Ethical Committee of the College of Medicine Research Council. The diagnosis of asthma was confirmed clinically by the treating pulmonologist and by the demonstration of airway obstruction and significant response to bronchodilator on testing with spirometry. For the minority of patients who could not perform spirometry, peak expiratory flow rate was used. Skin prick test (SPT) was used for screening patients for ABPM, as it is believed to be highly sensitive (5) . Pregnant women and patients taking continuous oral steroids were excluded from the study, since these conditions may interfere with the results of some of the tests. Patients on anti-histamines were retested after stopping them for 4-6 weeks. All patients with positive SPT underwent further immunological, microbiological and radiological assessment as detailed below.
ABPM was defined by the presence of a minimum of five of the following seven major criteria originally proposed by Rosenberg (4) , with the addition of specific IgE (5) 
IMMUNOLOGICAL INVESTIGATIONS

Skin prick test (SPT)
The skin prick test was performed in all patients using 17 fungal antigens. The panel included: Aspergillus fumigatus, A. niger, A. versicolor, A. clavatus, A. repens, Alternaria, Cladosporium, Rhizopus, Penicillium, Mucor, Trichophyton, Candida, Herbarum, Phoma, Fusarium, mould I and mould II (a mixture of fungal allergens), histamine (positive control), and negative control. The technique for SPT was followed as described by Pepys (13) . Skin test extracts 'Soluprick' were purchased from ALK Laboratories, Horsholm, Denmark. Immediate reactions were read after 10-15 min and were interpreted as positive only if wheal and flare measured 3 mm or more with a positive histamine control. 
MICROBIOLOGICAL STUDIES
Direct microscopy and culture
Sputa were collected of patients with positive SPT who were able to expectorate specimens. Smears were made and stained with Giemsa stain, then examined microscopically for fungal elements. The specimen was cultured on each of Sabouraud's dextrose agar and Sabouraud's dextrose agar with chloramphenicol and incubated at room temperature (26+18C) for up to 4 weeks before reporting as negative if no growth occurred. Cultures were examined periodically to detect any growth, and when growth was found, they were subcultured onto Sabouraud's dextrose agar slopes and identified using standard mycological methods.
PULMONARY FUNCTION TESTS
Spirometry was performed according to the American Thoracic Society (ATS) recommendations (14) . Measurements included the forced expiratory volume in 1 sec (FEV 1 ) and forced vital capacity (FVC), and were expressed as percentage of predicted values.
RADIOLOGICAL STUDIES
Chest radiographs (CXR) were performed for all patients with positive SPT. A high resolution computed tomography (HRCT) scan of the chest was done for patients with suspicious findings on CXR (e.g. mild bronchial dilatation or thickening). HRCT was done from the apex to the base (with around 18-20 slice cuts depending on the size of the thorax of the patients) or limited (with 1?5620 mm cuts from the aortic arch to the diaphragm and six cuts on expiration). All radiological material was reviewed by one pulmonary radiologist who was not aware of the results of the other investigations. The diagnostic findings for ABPM included central bronchiectasis (CB) and fleeting pulmonary shadows (FS) that are not explained by other causes such as infection, infarction or autoimmune diseases.
Results
During the study period 273 consecutive patients with asthma were evaluated. Nine patients were excluded (six pregnant women and three on chronic steroid therapy), leaving 264 patients for further evaluation.
CLINICAL CHARACTERISTICS
A total of 264 patients were screened with the skin prick test (SPT). The age of the patients ranged between 7 and 93 years, mean age and standard deviations were 38+17 years. One hundred and fifty (56.8%) were females and 114 (43?2%) were males. Two hundred and two patients (76?5%) had negative SPT and 62 (23?5%) had positive SPT to one or more fungal allergen. In the group with positive SPT 44 (71%) were females, as opposed to 106 (52?5%) in the group with negative SPT (P=0?01, Table 1 ). Before assessment, 50 (81%) of patients with positive SPT and 101 (50%) of patients with negative SPT were taking consistently inhaled corticosteroids (P50.001). There were few smokers (none in patients with positive SPT and four in patients with negative SPT). Ex-smokers were one and two in the two groups, respectively. The clinical features of patients according to the skin test result are shown in Table 1 . Cough was the only symptom showing a statistically significant difference. History of atopy (allergic rhinitis, conjunctivitis or dermatitis) was slightly higher in patients with positive SPT but the difference was not statistically significant.
IMMUNOLOGICAL INVESTIGATIONS
Skin prick test
Sixty-two (23%) out of 264 patients showed positive SPT to one or more of the allergens tested. Details are available for 53 patients (Table 2 ) and were as follows: 16 patients (30%) reacted to the mould I extract; 16 patients (30%) to Candida; 15 patients (28%) to Aspergillus niger; 14 patients (26%) to Alternaria; 12 patients (23%) to Aspergillus fumigatus; 12 patients (23%) to mould II; seven patients (13%) each to A. versicolor, A. clavatus, A. repens, Cladosprium, Penicillium; two patients (4%) to Trichophyton; and one (2%) to Mucor. There were no reactions to Herbarum, Phoma and Fusarium. Details of the remaining nine patients could not be located, although it was known for certain that they had positive SPT. (Table 2) . Twenty patients (37%) had a positive specific IgE test to at least one fungal allergen. Candida and Alternaria were the most prominent allergens showing positive reactions. The frequency of specific IgE antibodies to different allergens is as follows: Candida, 15 patients (28%); Alternaria, 14 patients (26%); A. fumigatus, 12 patients (22%); Cladosporium, 11 patients (20%); Rhizopus and Fusarium, 10 patients (19%) each; and Penicillium, Phoma and Mucor, nine patients (17%) each. Unfortunately, specimens from the remaining eight patients were not received by the laboratory. However, even if these patients were assumed to have positive results, none of them would have had sufficient other positive criteria for the diagnosis of ABPM. 
Eosinophil count
The range of the eosinophil counts was 10-2580 ml
71
. Seventeen patients (27%) had more than 400 eosinophils ml 71 in their peripheral blood.
MICROBIOLOGICAL STUDIES
Of the group of patients with positive SPT, 35 patients managed to provide sputum for fungal studies (Table 2) . Sputum smears for fungi showed hyphae in 16, yeast in two and were negative in the remaining specimens. Culture results for Aspergilli were as follows: five A. niger, and one each of A. fumigatus, A. flavus, A. terreus and Aspergillus spp. in patients with ABPA (Table 2) . A. niger was isolated from four patients and A. terreus from one patient. A. fumigatus was not isolated from any patient with ABPA. C. albicans was cultured from 13 patients, C. glabrata and C. parapsilosis from one patient each. C. albicans was associated with Aspergillus in two patients with a positive specific IgE (Table 3 , patient nos 1 and 2). C. albicans was also isolated solely from one patient but with a negative specific IgE and SPT, which indicates that a pathogenic role is unlikely.
PULMONARY FUNCTION TESTS
Two hundred and eleven patients had spirometry (46 with positive SPT and 165 with negative SPT). Patients with positive SPT had lower FEV 1 and FVC than patients with negative SPT (P-value for FEV 1 =0?0016 and for FVC=0?0037) as shown in Table 4 .
RADIOLOGICAL STUDIES
Chest radiographs of the 62 patients with positive SPT showed the following: 42 were normal, 17 showed nondiagnostic abnormalities, three showed fleeting shadows and one showed CB. Patients with abnormal CXR went on for HRCT scan, which showed CB in four patients.
PATIENTS WITH ABPM
Out of the 264 asthmatic patients screened with SPT, 62 (23%) had positive skin test reactions. Seven patients fulfilled five or more of the major criteria for the diagnosis of ABPM (Table 3) , i.e. a period prevalence of 2?7%, 95% confidence interval 1?3-5?4% (15) . Of those patients six were females and one only was male. Patients 1, 2 and 7 were referred from coastal cities in the south-west of Saudi Arabia, and the remainder were from central Arabia.
Discussion
To our knowledge, this is the first survey of ABPM in patients with asthma in the Middle East. Studies have shown that fungal allergens are prevalent both in the indoor and outdoor environment in Riyadh (2), as well as positive skin reactions to fungi in asthmatic patients (3) . Despite this, only one series of 10 patients with ABPA was reported in a retrospective study in Saudi Arabia from 1984 to 1994 (8) . It was thought that the low natural humidity in central Arabia (540%), which can inhibit the growth of fungi, might have contributed to the rarity of this syndrome (8) . This study shows period prevalence close to 3% for ABPM due to Aspergillus and Candida, suggesting that the disease is not uncommon but more likely overlooked among asthma patients attending our outpatient clinics.
In Western countries the reported frequencies ranged between 1 and 28% depending on the patient population and methods of the study. For example, in the U.K. an earlier study found a prevalence of 11% (9) . The criteria used to define ABPA in that study included: asthma, eosinophilia, a positive skin reaction to A. fumigatus and a positive sputum fungal culture. In Ireland, Donnelly et al. (10) found the period prevalence of ABPM due to Aspergillus and Candida to be just over 1% in an outpatient clinic between 1985 and 1988. They screened patients with asthma and eosinophilia or unexplained pulmonary infiltrates requiring a minimum of four criteria that included a positive serology to A. fumigatus or C. albicans. In the U.S.A. two surveys of ABPA were done on asthmatic patients with a positive skin reaction i.e. following methodology similar to the one used in our study. More strict criteria were used that included specific serological assays to Aspergillus and the radiological finding of central bronchiectasis. In the first, Greenberger and Patterson reported a prevalence of 6% (11) . Surprisingly, a much higher rate of 28% was found by Schwartz and Greenberger in the second survey in Cleveland, Ohio, U.S.A. (12) . They attributed this to the more rigorous and diligent testing they followed. These compare to 11% in our survey (i.e. seven out of 62 of our patients with positive skin tests). Differences in methodology and definitions make comparison between these studies difficult. Recent surveys have taken advantage of the more specific and sensitive serological and radiological testing allowing more accuracy in the diagnosis. The results of our survey, which adopted methodology similar to the U.S. surveys, suggest that the disease is not uncommon in central Arabia. It is important, therefore, to promote physicians' awareness to ABPM.
More obstacles follow when trying to establish the diagnosis. A number of criteria are required and these may not be all present at the point of the assessment during a 'quiescent' phase (5) . Moreover, ABPM activity may not be evident symptomatically (5). Therefore we think that the true period prevalence rate is underestimated. Vigilance is needed when following patients especially those known to have some positive criteria (three or four). Another difficulty is the acquisition of the specific serological tests and the proper antigen for skin testing. Most of the available serological tests and skin extracts are specified for A. fumigatus, the species implicated in the classical descriptions of the disease. By contrast, A. niger was more frequently isolated in our study. Misdiagnosis may occur if the proper antigens are not used, even though some crossreactivity exists. We used extracts made from species that were shown to be prevalent locally. Physicians in remote and less privileged hospitals may experience difficulties in obtaining resources and expertise to facilitate the diagnosis. Pitfalls that can lead to misdiagnosis were discussed in detail by Schwartz and Greenberger (12) .
It is interesting to notice that far more females were sensitized to fungal allergens, and also more had ABPM. Women in the reproductive years are thought to have higher rates of skin test reactivity than men (16) . This agespecific sex difference is evident in this study as most of the patients fell within this age range. Previous studies have shown conflicting results. ABPM was more frequent in females in the series reported by Donnelly et al. from Ireland (10) and from a study of cystic fibrosis patients in U.S.A. (17) . However, one retrospective British series had more males (18) . Another noteworthy observation is that patients with positive skin tests had poorer lung function than those with negative tests, confirming the results of the Cleveland-London study (1) . There were significantly more patients with positive skin test on inhaled steroids, which also supports the observation that this group had more severe asthma. Smoking was too uncommon among our patients to account for such a difference.
As mentioned above, although A. fumigatus received more emphasis in previous studies as having a more pathogenic role, A. niger was more predominant in this study. This may be explained by the higher prevalence of this fungus in the warm and arid climate. Isolation of this fungus in some of the cases may be merely the result of contamination. In our series Candida spp. is probably implicated in two patients. Some cases may be due to other fungi, as evident by the high frequency of positive skin tests and specific IgE to the panel of fungal allergens tested. ABPM due to these fungi could not be proven because the specific serological tests were not available commercially. Physicians should be alert to this possibility when the usual tests (such as eosinophilia, elevated serum IgE, and radiological signs) are positive but tests to Aspergillus or Candida are negative.
In conclusion, ABPM is not uncommon in this study from a university hospital in the central part of Saudi Arabia. Since asthma is a common disease, clinicians need to maintain a high index of suspicion for ABPM and keep in mind its diverse manifestations. Advances in the more specific serological and radiological investigations should facilitate the diagnosis, but such tests should include a wide range of the locally prevalent fungal species. Studies on the prevalence in other areas of Arabia would be interesting, particularly the south-western coastal areas.
